Eastwood Bio-Medical Canada Inc. (TSXV: EBM) has seen a modest decline in its stock price this week amid limited news coverage.
Eastwood Bio-Medical Canada Inc. is a small-cap company focused on marketing and distributing natural health products. This week, EBM.V shares experienced a slight dip, closing at C$1.86, down 0.53% for the day and 1.06% for the week. Despite recent volatility, the stock has shown significant gains over the past month and year.
Advertisement
Eastwood Bio-Medical Canada Inc
EBM.V
EBM.V
Eastwood Bio-Medical Canada Inc
WealthAwesomeMarket cap
$128.82M
52W high
$1.97
52W low
$0.34
1W change
-1.06%
Beta
0.35
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EBM's historical volatility
30-Day Vol
138.0%
Annualized
90-Day Vol
117.6%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$2.22
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.97 | C$1.23 – C$3.18 |
| 60 trading days | C$2.10 | C$1.07 – C$4.11 |
| 90 trading days | C$2.22 | C$0.97 – C$5.07 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors looking at Eastwood Bio-Medical should consider the company's recent performance metrics and the lack of significant news. The stock's upward trend over the past year contrasts with its current losses, suggesting a complex market sentiment.
EBM.V has surged 95.79% YTD despite recent declines.
The stock's recent performance reflects a broader trend of volatility in small-cap companies, highlighting the importance of careful analysis for potential investors.
Bull case
Eastwood Bio-Medical has shown impressive growth over the past year, with a year-to-date increase of 95.79%. The company’s focus on natural health products for metabolic disorders positions it well in the expanding health and wellness sector.
Bear case
Despite its growth potential, Eastwood Bio-Medical has reported significant net losses and has a negative profit margin of -28.1%. Additionally, the company’s low current ratio of 0.02 raises concerns about its ability to meet short-term obligations.
Recent Price Action
Eastwood Bio-Medical Canada Inc. (TSXV: EBM) has experienced a slight decline in its stock price this week. The stock closed at C$1.86, reflecting a decrease of 0.53% for the day and 1.06% for the week. However, the longer-term picture remains positive, with a remarkable year-to-date increase of 95.79% and a one-month gain of 43.08%. This performance highlights the volatility often seen in small-cap stocks.
Company News
Advertisement
Currently, there is no major news impacting Eastwood Bio-Medical Canada Inc. The company has limited recent media coverage, which is common for small-cap firms. The last available earnings reports indicate that Eastwood has been struggling with profitability, reporting a net loss in previous quarters. Investors should keep an eye on upcoming earnings reports for further insights into the company's financial health.
Technical Picture
From a technical perspective, Eastwood Bio-Medical's stock is trading above both its 50-day moving average (C$1.33) and its 200-day moving average (C$0.92), suggesting a bullish trend in the medium to long term. The stock has fluctuated within a 52-week range of C$0.34 to C$1.97, currently sitting at approximately 93% of its range. The stock's beta of 0.35 indicates lower volatility compared to the broader market, which may appeal to risk-averse investors.
Insider Activity
There is no significant insider activity reported for Eastwood Bio-Medical Canada Inc. This can be a key indicator for investors, as insider buying or selling can reflect management's confidence in the company's future prospects.
Price Action Summary
As of the last close, Eastwood Bio-Medical Canada Inc. (EBM.V) is trading at C$1.86, down 0.53% for the day. Investors should monitor the stock for further developments, particularly as the company continues to navigate its growth in the consumer staples sector.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
